Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
Fredrik Schjesvold, Paul G. Richardson, Thierry Façon, Adrían Alegre, Andrew Spencer, Artur Jurczyszyn, Kazutaka Sunami, Laurent Frenzel, Chang‐Ki Min, Sophie Guillonneau, Peggy L. Lin, Solenn Le-Guennec, Frank Campana, Helgi van de Velde, Samira Bensfia, Sara Bringhen
Abstract
Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed
Topics & Concepts
PomalidomideDexamethasoneMultiple myelomaInternal medicineSubgroup analysisMedicineOncologyRefractory (planetary science)LenalidomideBiologyMeta-analysisAstrobiologyMultiple Myeloma Research and TreatmentsPeptidase Inhibition and AnalysisProtein Degradation and Inhibitors